Role of Calcium sensing receptor (CaSR) in tumorigenesis

被引:38
|
作者
Singh, Navneet [1 ,2 ]
Promkan, Moltira [3 ]
Liu, Guangming [2 ,4 ]
Varani, James [5 ]
Chakrabarty, Subhas [6 ]
机构
[1] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA
[2] Simmons Canc Inst, Springfield, IL 62794 USA
[3] Mahidol Univ, Fac Med Technol, Salaya Phuttamonthon 73170, Nakhon Pathom, Thailand
[4] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[5] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA
[6] So Illinois Univ, Sch Med, Springfield, IL 62794 USA
关键词
CaSR; colon cancer; breast cancer; differentiation; drug resistance; tumor suppressor; COLON-CARCINOMA CELLS; THYMIDYLATE SYNTHASE EXPRESSION; PROSTATE-CANCER CELLS; BREAST-CANCER; VITAMIN-D; EXTRACELLULAR CALCIUM; COLORECTAL-CANCER; ESTROGEN-RECEPTOR; DIETARY CALCIUM; BETA-CATENIN;
D O I
10.1016/j.beem.2013.04.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The extracellular Ca2+-sensing receptor (CaSR) is a robust promoter of differentiation in colonic epithelial cells and functions as a tumor suppressor in colon cancer. CaSR mediates its biologic effects through diverse mechanisms. Loss of CaSR expression activates a myriad of stem cell-like molecular features that drive and sustain the malignant and drug-resistant phenotypes of colon cancer. This CaSR-null phenotype, however, is not irreversible and induction of CaSR expression in CaSR-null cells promotes cell death mechanisms and restores drug sensitivity. The CaSR also functions as a tumor suppressor in breast cancer and promotes cellular sensitivity to cytotoxic drugs. BRCA1 and CaSR functions intersect in breast cancer cells, and CaSR activation can rescue breast cancer cells from the deleterious effect of BRCA1 mutations. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:455 / 463
页数:9
相关论文
共 50 条
  • [31] A Short Primer on the Calcium Sensing Receptor: An Important Cog in the Colon Cancer Wheel?
    Ghevariya, Vishal
    Anand, Sury
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) : 279 - 284
  • [32] The role of the orphan nuclear receptor COUP-TFII in tumorigenesis
    Xu, Mafei
    Qin, Jun
    Tsai, Sophia Y.
    Tsai, Ming-jer
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (01) : 32 - 36
  • [33] Calcium sensing receptor suppresses human pancreatic tumorigenesis through a novel NCX1/Ca2+/β-catenin signaling pathway
    Tang, Bo
    Chow, Jimmy Y. C.
    Dong, Tobias Xiao
    Yang, Shi-Ming
    Lu, De-Sheng
    Carethers, John M.
    Dong, Hui
    CANCER LETTERS, 2016, 377 (01) : 44 - 54
  • [34] Roles for the calcium sensing receptor in primary and metastatic cancer
    Manning, A. T.
    O'Brien, N.
    Kerin, M. J.
    EJSO, 2006, 32 (07): : 693 - 697
  • [35] Calcium-Sensing Receptor Expression in Breast Cancer
    Busic-Pavlek, Iva
    Dumic-Cule, Ivo
    Kovacevic, Lucija
    Milosevic, Milan
    Delimar, Petra
    Korsa, Lea
    Marusic, Zlatko
    Prutki, Maja
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [36] The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion
    Kantham, Lakshmi
    Quinn, Steven J.
    Egbuna, Ogo I.
    Baxi, Khanjan
    Butters, Robert
    Pang, Jian L.
    Pollak, Martin R.
    Goltzman, David
    Brown, Edward M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (04): : E915 - E923
  • [37] BRCA1 suppresses the expression of survivin and promotes sensitivity to paclitaxel through the calcium sensing receptor (CaSR) in human breast cancer cells
    Promkan, Moltira
    Liu, Guangming
    Patmasiriwat, Pimpicha
    Chakrabarty, Subhas
    CELL CALCIUM, 2011, 49 (02) : 79 - 88
  • [38] The suppressive role of calcium sensing receptor in endometrial cancer
    Xin, Xiaoyan
    Zeng, Xianqin
    Feng, Dilu
    Hua, Teng
    Liu, Shuangge
    Chi, Shuqi
    Hu, Qinghua
    Wang, Hongbo
    SCIENTIFIC REPORTS, 2018, 8
  • [39] Quantitative assessment of the clinical susceptibility of calcium-sensing receptor polymorphisms in cancer patients
    Huang, Haohai
    Li, Tao
    Liao, Dan
    Zhu, Zhu
    Dong, Yong
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 755 - 763
  • [40] Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis
    Bogan, Christina
    Chen, Jin
    O'Sullivan, M. Gerard
    Cormier, Robert T.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) : 1366 - 1371